Calcipotriol abrogates cancer-associated fibroblast-derived IL-8-mediated oxaliplatin resistance in gastric cancer cells via blocking PI3K/Akt signaling
Acta Pharmacologica Sinica, Published online: 08 June 2022; doi:10.1038/s41401-022-00927-1Calcipotriol abrogates cancer-associated fibroblast-derived IL-8-mediated oxaliplatin resistance in gastric cancer cells via blocking PI3K/Akt signaling
Source: Acta Pharmacologica Sinica - Category: Drugs & Pharmacology Authors: Zhen-xiong Zhao Yan-qiu Zhang Hui Sun Zi-qi Chen Jin-jia Chang Xin Wang Xu Wang Cong Tan Shu-juan Ni Wei-wei Weng Meng Zhang Lei Wang Dan Huang Yun Feng Wei-qi Sheng Mi-die Xu Source Type: research
More News: Cancer | Cancer & Oncology | Drugs & Pharmacology | Eloxatin | Gastric (Stomach) Cancer | Gastroenterology | Men | Taclonex